U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07701928) titled 'Daridorexant for People With Insomnia and Alcohol Use Disorder Study' on June 30.

Brief Summary: The goal of this clinical trial is to see if a sleep medication, daridorexant (DTX), can help decrease drinking in people who have alcohol use disorder (AUD) and insomnia.

The main questions it aims to answer are:

* Can DTX decrease alcohol use in individuals with insomnia better than placebo?

* Can DTX increase sleep time and other sleep related outcomes better than placebo?

Participants will:

* Take prescribed medication (DTX or Placebo based on which group they are randomized to).

* Provide urine, breath, saliva, and blood sampl...